Ligand Pharmaceuticals Incorporated (LGND) ownership: Top institutional holder: BlackRock, Inc. ($591.35M). Insider activity: Net Seller (0 buys, 20 sells). 4 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 2961923.00 | $591.35M | 2026-03-31 |
| VANGUARD GROUP INC | 2073892.00 | $392.11M | 2025-12-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1100267.00 | $219.67M | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 1009891.00 | $201.62M | 2026-03-31 |
| BlackRock Fund Advisors | 1772705.00 | $180.13M | 2016-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 848089.00 | $169.32M | 2026-03-31 |
| Invesco Ltd. | 823604.00 | $164.43M | 2026-03-31 |
| STATE STREET CORP | 778856.00 | $155.50M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 |
Back to LGND overview · LGND earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.